Indian healthcare reform offers thriving pharmaceutical market opportunities: Interview with Deepak Sapra
August 25, 2020
Global Pharma Insights spoke to Deepak Sapra (below), CEO of Active Pharmaceutical Ingredients and Services at Dr. Reddy's Laboratories for his perspective on the current state of the Indian healthcare and pharmaceuticals sector and how it is providing opportunities for both domestic and multinational drugmakers and healthcare providers despite the challenges of the ongoing coronavirus pandemic.
To read the interview click here
+91 4049002253 Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.